|
FKRP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.456240E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.610200E-02 |
| Normal-vs-Stage2 |
2.900300E-02 |
| Normal-vs-Stage3 |
1.060200E-03 |
| Normal-vs-Stage4 |
3.404300E-03 |
| Stage1-vs-Stage2 |
3.057400E-01 |
| Stage1-vs-Stage3 |
8.832000E-02 |
| Stage1-vs-Stage4 |
1.133410E-01 |
| Stage2-vs-Stage3 |
8.823600E-01 |
| Stage2-vs-Stage4 |
8.047800E-01 |
| Stage3-vs-Stage4 |
8.764000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.006000E-04 |
| Normal-vs-AfricanAmerican |
3.340600E-01 |
| Normal-vs-Asian |
7.983600E-01 |
| Caucasian-vs-AfricanAmerican |
5.63319999999923E-05 |
| Caucasian-vs-Asian |
1.689980E-01 |
| AfricanAmerican-vs-Asian |
8.246000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56194999999526E-05 |
| Normal-vs-Female |
6.476000E-01 |
| Male-vs-Female |
5.07550000028445E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.995700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.259500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.210000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.452150E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.128000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.650600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.695600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.020000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.269600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.562800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.383300E-04 |
| Normal-vs-Grade 2 |
4.722100E-02 |
| Normal-vs-Grade 3 |
9.74169999999885E-05 |
| Normal-vs-Grade 4 |
7.990700E-04 |
| Grade 1-vs-Grade 2 |
2.035800E-04 |
| Grade 1-vs-Grade 3 |
2.80299999988465E-07 |
| Grade 1-vs-Grade 4 |
1.81939999999159E-05 |
| Grade 2-vs-Grade 3 |
7.298900E-03 |
| Grade 2-vs-Grade 4 |
3.345600E-02 |
| Grade 3-vs-Grade 4 |
7.669000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.526100E-02 |
| Normal-vs-ccB subtype |
9.72360000000005E-05 |
| ccA subtype-vs-ccB subtype |
3.481700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.121110E-03 |
| Normal-vs-N1 |
4.224900E-04 |
| N0-vs-N1 |
1.062990E-01 |
|
|
